Carrasco N - Search Results

1

The Na+/I- symporter mediates iodide uptake in breast cancer metastases and can be selectively down-regulated in the thyroid.

Wapnir IL, Goris M, Yudd A, Dohan O, Adelman D, Nowels K, Carrasco N. Wapnir IL, et al. Among authors: carrasco n. Clin Cancer Res. 2004 Jul 1;10(13):4294-302. doi: 10.1158/1078-0432.CCR-04-0074. Clin Cancer Res. 2004. PMID: 15240514

2

Thyroid Na+/I- symporter. Mechanism, stoichiometry, and specificity.

Eskandari S, Loo DD, Dai G, Levy O, Wright EM, Carrasco N. Eskandari S, et al. Among authors: carrasco n. J Biol Chem. 1997 Oct 24;272(43):27230-8. doi: 10.1074/jbc.272.43.27230. J Biol Chem. 1997. PMID: 9341168 Free article.

3

Hypothyroidism in transgenic mice expressing IFN-gamma in the thyroid.

Caturegli P, Hejazi M, Suzuki K, Dohan O, Carrasco N, Kohn LD, Rose NR. Caturegli P, et al. Among authors: carrasco n. Proc Natl Acad Sci U S A. 2000 Feb 15;97(4):1719-24. doi: 10.1073/pnas.020522597. Proc Natl Acad Sci U S A. 2000. PMID: 10677524 Free PMC article.

4

Molecular study of the sodium-iodide symporter (NIS): a new field in thyroidology.

Dohan O, De la Vieja A, Carrasco N. Dohan O, et al. Among authors: carrasco n. Trends Endocrinol Metab. 2000 Apr;11(3):99-105. doi: 10.1016/s1043-2760(00)00237-x. Trends Endocrinol Metab. 2000. PMID: 10707050

5

Molecular analysis of the sodium/iodide symporter: impact on thyroid and extrathyroid pathophysiology.

De La Vieja A, Dohan O, Levy O, Carrasco N. De La Vieja A, et al. Among authors: carrasco n. Physiol Rev. 2000 Jul;80(3):1083-105. doi: 10.1152/physrev.2000.80.3.1083. Physiol Rev. 2000. PMID: 10893432 Free article. Review.

6

The mammary gland iodide transporter is expressed during lactation and in breast cancer.

Tazebay UH, Wapnir IL, Levy O, Dohan O, Zuckier LS, Zhao QH, Deng HF, Amenta PS, Fineberg S, Pestell RG, Carrasco N. Tazebay UH, et al. Among authors: carrasco n. Nat Med. 2000 Aug;6(8):871-8. doi: 10.1038/78630. Nat Med. 2000. PMID: 10932223

7

The endogenous mammary gland Na(+)/I(-) symporter may mediate effective radioiodide therapy in breast cancer.

Zuckier LS, Dadachova E, Dohan O, Carrasco N. Zuckier LS, et al. Among authors: carrasco n. J Nucl Med. 2001 Jun;42(6):987-8. J Nucl Med. 2001. PMID: 11390567 Free article. No abstract available.

8

Rapid communication: predominant intracellular overexpression of the Na(+)/I(-) symporter (NIS) in a large sampling of thyroid cancer cases.

Dohán O, Baloch Z, Bánrévi Z, Livolsi V, Carrasco N. Dohán O, et al. Among authors: carrasco n. J Clin Endocrinol Metab. 2001 Jun;86(6):2697-700. doi: 10.1210/jcem.86.6.7746. J Clin Endocrinol Metab. 2001. PMID: 11397873

9

Journey of the iodide transporter NIS: from its molecular identification to its clinical role in cancer.

Riedel C, Dohán O, De la Vieja A, Ginter CS, Carrasco N. Riedel C, et al. Among authors: carrasco n. Trends Biochem Sci. 2001 Aug;26(8):490-6. doi: 10.1016/s0968-0004(01)01904-1. Trends Biochem Sci. 2001. PMID: 11504625 Review.

10

Na(+)/I(-) symporter activity requires a small and uncharged amino acid residue at position 395.

Dohán O, Gavrielides MV, Ginter C, Amzel LM, Carrasco N. Dohán O, et al. Among authors: carrasco n. Mol Endocrinol. 2002 Aug;16(8):1893-902. doi: 10.1210/me.2002-0071. Mol Endocrinol. 2002. PMID: 12145342

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

236 results

Search Page

Filters